NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
Receptor heterogeneity in cancer is a major limitation of molecular targeting for cancer therapeutics. Single-receptor-targeted treatment exerts selection pressures that result in treatment escape for low-receptor-expressing tumor subpopulations. To overcome this potential for heterogeneity-driven r...
Main Authors: | Shazia Bano, Girgis Obaid, Joseph W. R. Swain, Marina Yamada, Brian W. Pogue, Kenneth Wang, Tayyaba Hasan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/8/2390 |
Similar Items
-
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines
by: Karolin Ebert, et al.
Published: (2020-10-01) -
Use of Spectroscopic, Zeta Potential and Molecular Dynamic Techniques to Study the Interaction between Human Holo-Transferrin and Two Antagonist Drugs: Comparison of Binary and Ternary Systems
by: Mohammad Reza Saberi, et al.
Published: (2012-03-01) -
Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice?
by: Giuliani Jacopo, et al.
Published: (2014-04-01) -
Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells
by: Yoseop Kim, et al.
Published: (2019-10-01) -
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
by: Mellor James D, et al.
Published: (2013-01-01)